Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Rapamycin in the Treatment of Crohn's Disease-related Stricture

NCT02675153 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT02675153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Rapamycin in the Treatment of Crohn's Disease-related Stricture
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2015
Completion date
October 31, 2020
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's diseases